Pharmaceutical firms aggressively moved jobs out to offshore low-cost locations and now face pressure from the Trump Administration to move work back to the US. There’s a clear path for doing this, and companies in other industries can follow the same path.

from Forbes – Tech http://ift.tt/2o7H47n
via IFTTT